Human metapneumovirus: a newly emerging respiratory pathogen.

Area of Science:

• Virology
• Infectious Diseases
• Epidemiology

Background:

• Respiratory tract infections (RTIs) are a significant global health concern, particularly in infants and children.
• The etiology of many RTIs remains unknown, highlighting the need for identifying novel viral pathogens.
• Advances in molecular diagnostics facilitate the discovery of new infectious agents.

Purpose of the Study:

• To review the recent discovery of a novel respiratory virus, human metapneumovirus (hMPV).
• To describe the clinical and epidemiological characteristics of hMPV infections.
• To understand the role of hMPV as a cause of respiratory tract infections.

Main Methods:

• Discovery of hMPV through genetic studies of respiratory samples.
• Clinical case analysis of patients with hMPV infection.
• Seroepidemiologic studies to assess population exposure to hMPV.
• Comparison of hMPV prevalence with other common respiratory viruses.

Main Results:

• hMPV was identified as a paramyxovirus, the first human pathogen in the genus Metapneumovirus.
• Seroepidemiologic data suggest widespread exposure to hMPV by age five.
• hMPV is estimated to cause approximately 10% of RTIs where other common viruses are not detected.
• hMPV infection presents with symptoms including cough, dyspnea, wheeze, and hypoxia in both children and adults.
• The virus appears to have a worldwide distribution and seasonal occurrence.

Conclusions:

• hMPV is an emerging respiratory pathogen.
• It contributes significantly to both upper and lower respiratory tract infections in all age groups.
• Further research is warranted to fully elucidate the impact and management of hMPV.